Category: Societal Applications
-
EPITA project to spur innovative new accelerator technologies launches at CERN
EPITA project to spur innovative new accelerator technologies launches at CERN A new multi-year accelerator technology projects gets underway By Thomas Brent The EU-funded EPITA project officially launched this week with a two-day kick-off event hosted at CERN, the coordinating institution. Funded through Horizon Europe’s Research Infrastructures programme, the project will develop innovative technologies to
-
CERN leads project to make EU scientific data more accessible
Sharing research data openly is transforming science, but it comes with challenges. Since 2021, EU-funded projects have been required to make their data FAIR: findable, accessible, interoperable and reusable.
-
CERN’s Medipix3 technology on track to help more patients
Originally derived from a technology developed to explore the fundamental nature of the Universe, Medipix3 technology now powers a medical scanner that is on track to benefit an increased number of patients. MARS Bioimaging Ltd has received 510(k) clearance from the US Food and Drug Administration (FDA) for its portable photon-counting CT scanner for upper-limb imaging, allowing the system…
-
CERN Timepix chips fly to the Moon
At 00:35 CEST today, the Artemis II mission successfully launched, marking the first human journey to the Moon since 1972. During their ten-day journey aboard the Orion spacecraft, the four astronauts are expected to receive tens of millisieverts
-
Love is in the air at CERN’s HEARTS facility
This Valentine’s Day, CERN shines a light on its HEARTS testing facility, loved by those who recently tested their components for the harsh conditions of space. Late last year, the Large Hadron Collider ended a record-breaking year by colliding lead ions. The HEARTS@CERN facility took advantage of this period to test radiation effects with lead…
-
Advancing Access to Radiotherapy – STELLA Project Concludes 18-Month Phase
The STELLA (Smart Technologies to Extend Lives with Linear Accelerators) project has completed an 18-month research and system design phase funded by the U.S. Department of Energy. Led by the International Cancer Expert Corps (ICEC) and CERN, with academic partners from the Universities of Cambridge, Lancaster, and Oxford, the project focuses on addressing long-standing gaps…
-
Advancing cancer therapy with next-gen radionuclides
Nuclear medicine uses radionuclides for imaging and therapeutic purposes. These unstable nuclei decay by emitting radiation, which will damage or destroy the cancer cells. Over the past decade, the “theranostic” approach has emerged, combining imaging and therapy to tailor treatment to the individual patient.
-
Catalysing Impact: Superconductors as an opportunity for Science & Society
As the two-day event “Catalysing Impact – Superconductivity for Global Challenges” drew to a close, the atmosphere at CERN was one of shared purpose and optimism. Held on 1–2 December 2025 in the Main Auditorium, the event gathered leading researchers, industry representatives, investors and policymakers to explore how collaborations in superconducting technologies can advance particle…
-
Superconductivity for addressing global challenges
A CERN event brings together researchers, industry leaders and decision makers to accelerate the use of superconducting technologies for societal applications
-
The future of particle therapy
When targeting tumours, protons and heavy ions offer distinct advantages compared to conventional X-ray radiotherapy. PTCOG president Marco Durante describes an exciting future for the technology and shares his vision for closer international cooperation between medicine, academia and industry.